Yttrium-90 Radioembolization for Hepatocellular Carcinoma

90Y radioembolization refers to the selective, transcatheter, and intra-arterial injection of micrometer-sized particles loaded with the radioisotope yttrium-90 for the treatment of primary and metastatic hepatic malignancies. In the treatment of intermediate- and advanced-stage hepatocellular carcinoma, 90Y radioembolization provides favorable outcomes with minimal side effects, offering an alternative treatment option to other transarterial therapies, such as bland embolization and chemoembolization.
Source: Seminars in Nuclear Medicine - Category: Nuclear Medicine Authors: Source Type: research